Comparing Praluent vs Simvastatin
Praluent (alirocumab) | Simvastatin |
|
---|
Praluent (alirocumab) | Simvastatin |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Praluent is a PCSK9 inhibitor that may be used to reduce LDL-C levels in people with primary hyperlipidemia, genetically high cholesterol, or to reduce the risk of a heart attack, stroke, or... View more |
Prescription only
Simvastatin is effective at lowering cholesterol; however, it may cause muscle pain, particularly at higher dosages. Should not be used by people with active liver disease or in women planning a... View more |
Related suggestions High Cholesterol
Cardiovascular Risk Reduction
High Cholesterol, Familial Heterozygous
High Cholesterol, Familial Homozygous
Popular comparisons
|
|||||||
More about Praluent (alirocumab) | More about Simvastatin | ||||||||
Ratings & Reviews | |||||||||
Praluent has an average rating of 6.3 out of 10 from a total of 306 ratings on Drugs.com. 48% of reviewers reported a positive effect, while 31% reported a negative effect. |
Simvastatin has an average rating of 4.8 out of 10 from a total of 131 ratings on Drugs.com. 30% of reviewers reported a positive effect, while 48% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Praluent side effects |
View all Simvastatin side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
Lower cost generic |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Simvastatin prices |
||||||||
Dosage Forms | |||||||||
|
|
||||||||
Brand Names | |||||||||
N/A |
FloLipid, Zocor | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
480 hours |
N/A |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 3 drugs are known to interact with Praluent:
|
A total of 340 drugs are known to interact with Simvastatin:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||
Disease Interactions | |||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||
First Approval Date | |||||||||
July 24, 2015 |
December 23, 1991 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
|
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.